An engineered glioblastoma model yields macrophage-secreted drivers of invasion
While the accumulation of tumor-associated macrophages (TAMs) in glioblastoma (GBM) has been well documented, targeting TAMs has thus far yielded limited clinical success in slowing GBM progression due, in part, to an incomplete understanding of TAM function. Using an engineered 3D hydrogel-based model of the brain tumor microenvironment (TME), we show that M2-polarized macrophages stimulate transcriptional and phenotypic changes in GBM stem cells (GSCs) closely associated with the highly aggressive and invasive mesenchymal subtype. By combining proteomics with GBM patient single-cell transcriptomics, we identify multiple TAM-secreted proteins with putative proinvasive functions and validate TGF-β induced (TGFBI, also known as BIGH3) as a targetable TAM-secreted tumorigenic factor. Our work highlights the utility of coupling multiomics analyses with engineered TME models to investigate TAM-cancer cell crosstalk and offers insights into TAM function to guide TAM-targeting therapies.
Authors
- Kelsey Hopland
- Sanjay Kumar (ORCID: https://orcid.org/0000-0002-9996-4883)
- Manish K. Aghi (ORCID: https://orcid.org/0000-0002-2949-2227)
- Erin Akins (ORCID: https://orcid.org/0000-0002-5359-5891)
- Robert C. Osorio (ORCID: https://orcid.org/0000-0002-7669-2176)
- Zaki Abou-Mrad (ORCID: https://orcid.org/0000-0001-6387-8396)
- Dana E. Wilkins (ORCID: https://orcid.org/0000-0002-0065-8828)
- Kenny K.H. Yu
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- University of California, San Francisco (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- JCI Insight
- Published
- 2025-08-22
- DOI
- https://doi.org/10.1172/jci.insight.181903
- Citations
- 2
- Primary Topic
- Immune cells in cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.59
Funders
- National Science Foundation
- National Institutes of Health
- UC Berkeley College of Chemistry
- National Cancer Institute